Company news
Resonance Health Ltd (ASX:RHT) news
Resonance Health Ltd news releases on 6ix. Latest, Apr 12, 2017: Evidence Building for HepaFat-Scan
Press releases — page 3
Evidence Building for HepaFat-Scan
April 12, 2017
Cancer Survivor Campaign Update
March 23, 2017
Half year report
February 28, 2017
Maylasian NAFLD - Diabetes Study
January 12, 2017
Results Recommending Use of FerriScan in Sickle Cell Disease
November 10, 2016
Resonance Health commences involvement in diabetes study
October 13, 2016
Bone Marrow Iron - Regulatory Submission
September 23, 2016
Expansion of Involvement in Pharmaceutical Clinical Trial
September 7, 2016
HepaFat-Scan International Scientific Journal
August 10, 2016
Operational Update
June 14, 2016
New UK Standards recommend FerriScan
May 30, 2016
Appendix 4C Quarterly Cashflow Report
April 29, 2016
Placement and entitlements offer to raise $5.1million
March 30, 2016
Half Year Accounts
February 25, 2016
New Clinical Trial
February 11, 2016
CSIRO Collaboration
February 10, 2016